Page last updated: 2024-12-10
viomellein
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
viomellein: metabolite of Penicillium viridicatum causing hepatic lesions in mice [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 3033108 |
MeSH ID | M0061727 |
Synonyms (19)
Synonym |
---|
8-(3,4-dihydro-9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-1h-naphtho(2,3-c)pyran-8-yl)-3,4-dihydro-6- hydroxy-9-methoxy-3-methyl-1h-naphtho(1,2-c)pyran-1,7,10-trione |
viomellein |
brn 4630536 |
(8,8'-bi-1h-naphtho(2,3-c)pyran)-1,1',6,9-tetrone, 3,3',4,4'-tetrahydro-7,7'-dimethoxy-3,3'-dimethyl-9',10,10'-trihydroxy-, (r-(r*,r*))- |
(3r)-8-[(3r)-9,10-dihydroxy-7-methoxy-3-methyl-1-oxo-3,4-dihydrobenzo[g]isochromen-8-yl]-10-hydroxy-7-methoxy-3-methyl-3,4-dihydrobenzo[g]isochromene-1,6,9-trione |
55625-78-0 |
unii-9r5rc7qx9b |
5-19-07-00211 (beilstein handbook reference) |
9r5rc7qx9b , |
AKOS030213230 |
DTXSID00204162 |
mfcd01740396 |
(8,8'-bi-1h-naphtho(2,3-c)pyran)-1,1',6,9-tetrone, 3,3',4,4'-tetrahydro-9',10,10'-trihydroxy-7,7'-dimethoxy-3,3'-dimethyl-, (r-(r*,r*))- |
(3r,3'r)-3,3',4,4'-tetrahydro-9',10,10'-trihydroxy-7,7'-dimethoxy-3,3'-dimethyl(8,8'-bi-1h-naphtho(2,3-c)pyran)-1,1',6,9-tetrone |
(8,8'-bi-1h-naphtho(2,3-c)pyran)-1,1',6,9-tetrone, 3,3',4,4'-tetrahydro-9',10,10'-trihydroxy-7,7'-dimethoxy-3,3'-dimethyl-, (3r,3'r)- |
[8,8'-bi-1h-naphtho[2,3-c]pyran]-1,1',6,9-tetrone,3,3',4,4'-tetrahydro-9',10,10'-trihydroxy-7,7'-dimethoxy-3,3'-dimethyl-,(3r,3'r)- |
Q2527503 |
8-(3,4-dihydro-9,10-dihydroxy-7-methoxy-3-methyl- 1-oxo-1h-naphtho(2,3-c)pyran-8-yl)-3,4-dihydro-6- hydroxy-9-methoxy-3-methyl-1h-naphtho(1,2-c)pyran- 1,7,10-trione |
brn4630536 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (45.45) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 19.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.72) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |